SHANGHAI – The first Wuxi Healthcare Forum held in China was a notably upbeat and optimistic affair. Several panel moderators encouraged blue sky thinking by asking a variant on the same question: What technologies and advances are the most exciting or have the greatest potential to disrupt the industry in the next five to 10 years? Speakers from China, the U.K., Europe, the U.S. and Canada gamely shared their prognostications for the future. Read More
TOKYO – An ongoing downturn in global trade may turn out to be unexpectedly severe, but in the midst of the ongoing difficulties there may be opportunities for biotech companies. That was the opinion of industry executives speaking at the Bio Asia International Conference last week, as they generally agreed that this year should be a good one for biotech stocks, in no small part thanks to an expected recovery from the sharp correction during the last quarter of 2018. Read More
SEATTLE – Clinical trial data for both approved and experimental HIV drugs were presented on the last day of the Conference on Retroviruses and Opportunistic Infections (CROI). Read More
As the Philippine Department of Justice (PDOJ) said it found probable cause to indict Sanofi SA and government officials over deaths caused by the Paris-based pharma giant's dengue vaccine, the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) reviewed the BLA for the product in an uneventful session. Read More
Shionogi & Co. Ltd., of Osaka, Japan, and Akili Interactive, a digital medicine company based in Boston, said they entered a deal to commercialize Akili's digital medicines, AKL-T01 and AKL-T02, in Japan and Taiwan. Read More
